Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123830262 | 12383026 | 2 | F | 201201 | 20160628 | 20160518 | 20160701 | PER | PHEH2016US012182 | NOVARTIS | 75.85 | YR | F | Y | 0.00000 | 20160701 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123830262 | 12383026 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 200 MG, BID | 21588 | 200 | MG | TABLET | BID | ||||||
| 123830262 | 12383026 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | BREAKING HER 400MG TABLET IN HALF TO TAKE 200MG IN THE AM AND 200MG IN THE PM) | 21588 | TABLET | BID | ||||||||
| 123830262 | 12383026 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, BID | U | 0 | 25 | MG | TABLET | BID | |||||
| 123830262 | 12383026 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 123830262 | 12383026 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 50 UG, QD | U | 0 | 50 | UG | TABLET | QD | |||||
| 123830262 | 12383026 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, QD | Y | 0 | 25 | MG | PATCH | QD | |||||
| 123830262 | 12383026 | 7 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Oral | 0.3 MG, QD | U | 0 | .3 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123830262 | 12383026 | 1 | Chronic myeloid leukaemia |
| 123830262 | 12383026 | 3 | Hypertension |
| 123830262 | 12383026 | 4 | Blood cholesterol increased |
| 123830262 | 12383026 | 5 | Hypothyroidism |
| 123830262 | 12383026 | 6 | Hypertension |
| 123830262 | 12383026 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123830262 | 12383026 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123830262 | 12383026 | Breast pain | |
| 123830262 | 12383026 | Deep vein thrombosis | |
| 123830262 | 12383026 | Diarrhoea | |
| 123830262 | 12383026 | Eye swelling | |
| 123830262 | 12383026 | Fall | |
| 123830262 | 12383026 | Impaired healing | |
| 123830262 | 12383026 | Irritable bowel syndrome | |
| 123830262 | 12383026 | Joint injury | |
| 123830262 | 12383026 | Joint swelling | |
| 123830262 | 12383026 | Keloid scar | |
| 123830262 | 12383026 | Nausea | |
| 123830262 | 12383026 | Skin sensitisation | |
| 123830262 | 12383026 | Wound complication | |
| 123830262 | 12383026 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123830262 | 12383026 | 1 | 201201 | 0 |